This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Autism Registry for French Guiana (REGUYAUT)

This study is currently recruiting participants.
See Contacts and Locations
Verified September 2016 by Centre Hospitalier de Cayenne
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier de Cayenne
ClinicalTrials.gov Identifier:
NCT02903732
First received: September 6, 2016
Last updated: September 13, 2016
Last verified: September 2016
  Purpose
The objective of the autism registry is to estimate the prevalence of autism in French Guiana in the cohort of children aged 8 years. Secondary objectives are to determine the prevalence of comorbidities, and to determine the theoretical and actual orientation of these children regarding care and education in a territory with significant structural deficits relative to mainland France. The outcomes of this registry will be to guide decision makers in their funding priorities to improve, screening, diagnosis, care and education for children on the autistic spectrum

Condition Intervention
Autism Spectrum Disorder Other: observational

Study Type: Observational [Patient Registry]
Study Design: Time Perspective: Cross-Sectional
Target Follow-Up Duration: 10 Years
Official Title: Autism Registry for French Guiana

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier de Cayenne:

Primary Outcome Measures:
  • autism spectrum disorder [ Time Frame: 1 year (the year at age 8) ]
    the number of 8 year old children with a diagnosis of autism spectrum disorder in a given year relative to the total population of children aged 8 years old in that given year


Estimated Enrollment: 400
Study Start Date: September 2015
Estimated Study Completion Date: December 2020
Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: observational
    registry
  Eligibility

Ages Eligible for Study:   8 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children aged 8 years will be the denominator. the numerator is children who are seeking assistance for care or educational purposes at the unique administration dealing with handicap in French Guiana
Criteria

Inclusion Criteria:

  • children aged 8 years with a diagnosis of autism spectrum disorder

Exclusion Criteria:

  • refusal to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02903732

Locations
France
Centre Hospitalier de Cayenne Recruiting
Cayenne, French Guiana, France, 97306
Contact: Mathieu Nacher, MD, PhD    0594395024 ext 5024    mathieu.nacher@ch-cayenne.fr   
Sponsors and Collaborators
Centre Hospitalier de Cayenne
  More Information

Responsible Party: Centre Hospitalier de Cayenne
ClinicalTrials.gov Identifier: NCT02903732     History of Changes
Other Study ID Numbers: REGUYAUT
Study First Received: September 6, 2016
Last Updated: September 13, 2016

Additional relevant MeSH terms:
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 22, 2017